TMCnet News

Research and Markets: Global In Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020 - Revenue is Expected to Reach $74.65 Billion
[November 26, 2014]

Research and Markets: Global In Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020 - Revenue is Expected to Reach $74.65 Billion


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/5z9v4v/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.

The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020.

Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top impacting fators of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market.



Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market.

Scope of the Report


KEY MARKET SEGMENTS

  • Immunoassays
  • Clinical Chemistry
  • Point Of Care
  • Molecular Diagnostics
  • Hematology
  • Coagulation
  • Microbiology
  • Other clinical techniques

MARKET BY PRODUCT TYPE

  • Instruments
  • Reagents
  • Data management systems
  • Services

MARKET BY USABILITY

  • Disposable
  • Reusable

MARKET BY APPLICATIONS

  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing
  • HIV/AIDS
  • Others

MARKET BY END USER

  • Hospitals
  • Laboratories
  • Academics
  • Point of Care Testing
  • Others

Companies mentioned:

  • Abbot Laboratories
  • Alere Inc
  • Arkray Inc
  • Bayer AG
  • Becton Dickinson & Company
  • Biomerieux
  • Dahaner Corporation
  • Johnson & Johnson
  • Roche Diagnostics
  • Siemens (News - Alert)
  • Sysmex Corp.

For more information visit http://www.researchandmarkets.com/research/5z9v4v/global_in_vitro


[ Back To TMCnet.com's Homepage ]